Selected Publications
-
article
- Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma.. Transplantation and cellular therapy. 2024
- CNS Bridging Radiotherapy Achieves Rapid Cytoreduction Prior to CAR T Cell Therapy for Aggressive B-Cell Lymphoma.. Blood advances. 2024
- Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile.. British journal of haematology. 2024
- Transplantation-Associated Altered Mentation and Encephalopathy: A New Classification for Acute Neurocognitive Changes Associated with Hematopoietic Cell Transplantation from the ASTCT Committee on Practice Guidelines.. Transplantation and cellular therapy. 30:646-662. 2024
- BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.. American journal of hematology. 99:1180-1183. 2024
- Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review.. Journal of geriatric oncology. 15:-. 2024
- Transplantation and Cellular Therapy for Older Adults-The MSK Approach.. Current hematologic malignancy reports. 19:82-91. 2024
- Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia.. American journal of hematology. 98:1869-1876. 2023
- The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation.. British journal of haematology. 203:840-851. 2023
- Analysis of Disparities in Time to Allogeneic Transplantation in Adults with Acute Myelogenous Leukemia.. Blood advances. 7:3824-3833. 2023
- Prospective Geriatric Assessment and Geriatric Consultation in CAR T-cell Therapy for Older Lymphoma Patients.. Blood advances. 7:3501-3505. 2023
- CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results.. Nature medicine. 29:1710-1717. 2023
- Lack of disease control remains a major barrier to transplant for older patients with AML.. Bone marrow transplantation. 58:1054-1056. 2023
- Older Adults With Newly Diagnosed AML: Hot Topics for the Practicing Clinician.. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. -. 2023
- The Transplant Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Patients.. Transplantation and cellular therapy. 29:632.e1-632.e10. 2023
- Open-Label, Pilot Study of Romiplostim for Thrombocytopenia After Autologous Hematopoietic Cell Transplantation.. Blood advances. 7:1536-1544. 2023
- Characteristics of Distress and Support Group Participation in Caregivers of Older Allogeneic Hematopoietic Cell Transplantation Patients: A Single Institution Retrospective Review.. Journal of the advanced practitioner in oncology. 14:127-137. 2023
- Bridging Radiation Rapidly and Effectively Cytoreduces High Risk Relapsed/Refractory Aggressive B-Cell Lymphomas Prior to Chimeric Antigen Receptor T-Cell Therapy.. Transplantation and cellular therapy. 29:259.e1-259.e10. 2022
- Allogeneic Transplantation for Older Patients with Acute Myeloid Leukemia: The Dawn of a New Era.. Transplantation and cellular therapy. 28:793-794. 2022
- Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma.. Leukemia. 37:154-163. 2022
- Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients.. Leukemia. 37:1006-1017. 2022
- Racial Disparities in Access to Alternative Donor Allografts Persist in the Era of "Donors for All".. Blood advances. 6:5625-5629. 2022
- Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma.. Transplantation and cellular therapy. 28:751.e1-751.e7. 2022
- Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies.. Cancer cell. 40:590-591. 2022
- Prephase rituximab/prednisone therapy and aging-related, pro-inflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma. Haematologica. 107:1144-1152. 2022
- The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT.. Blood advances. 6:1525-1535. 2022
- Allogeneic hematopoietic cell transplantation for older patients.. Hematology. American Society of Hematology. Education Program. 2021:254-263. 2021
- TP53. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40:369-381. 2021
- Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection.. Transplantation and cellular therapy. 28:55.e1-55.e5. 2021
- Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy.. Transplantation and cellular therapy. 27:771.e1-771.e10. 2021
- Immune Reconstitution in the Aging Host: Opportunities for Mechanism-Based Therapy in Allogeneic Hematopoietic Cell Transplantation.. Frontiers in immunology. -. 2021
- Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.. Bone marrow transplantation. 56:2108-2117. 2021
- Breaking the Age Barrier: Physicians' Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults.. Transplantation and cellular therapy. 27:617.e1-617.e7. 2021
- Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves.. Transplantation and cellular therapy. 27:438.e1-438.e6. 2021
- Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma.. Haematologica. 106:255-258. 2021
- Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies.. Blood advances. 4:4669-4678. 2020
- Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation.. Bone marrow transplantation. 56:289-292. 2020
- Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes.. Blood advances. 4:2810-2820. 2020
- Impact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma.. Bone marrow transplantation. 55:2331-2334. 2020
- The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients.. Leukemia & lymphoma. 61:1833-1841. 2020
- Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients.. Journal of palliative medicine. 23:1653-1657. 2020
- Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.. The New England journal of medicine. 382:822-834. 2020
- Evidence-Based Minireview: Longitudinal geriatric assessment in quality care for older patients with hematologic malignancies.. Hematology. American Society of Hematology. Education Program. 2019:59-62. 2019
- Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies.. Bone marrow transplantation. 55:157-164. 2019
- Hematopoietic-cell transplantation for lymphoma in the era of genetically engineered cellular therapy: it's not quite time to scrap the old vehicle for the new car.. Current opinion in hematology. 26:288-293. 2019
- Feasibility of a patient-reported, electronic geriatric assessment tool in hematopoietic cell transplantation - a single institution pilot study.. Leukemia & lymphoma. 60:3308-3311. 2019
- Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults.. Blood advances. 3:12-20. 2019
- Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations.. British journal of haematology. 184:1006-1010. 2018
- End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer center.. Bone marrow transplantation. 54:700-706. 2018
- Pretransplant comprehensive geriatric assessment in hematopoietic cell transplantation: a single center experience.. Bone marrow transplantation. 53:1184-1187. 2018
- Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.. The oncologist. 23:468-473. 2017
- Potentially inappropriate medication use in elderly non-Hodgkin lymphoma patients is associated with reduced survival and increased toxicities.. British journal of haematology. 180:267-270. 2017
- Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma.. Blood. 130:2180-2185. 2017
- PEComa with Transcription Factor E3 Overexpression: A Diagnostic and Therapeutic Challenge.. Case reports in oncology. 10:531-533. 2017
- Checkpoint Inhibition in Hodgkin Lymphoma: Saving the Best for Last?. Oncology (Williston Park, N.Y.). 30:914-20. 2016
- Development of highly aggressive mantle cell lymphoma after sofosbuvir treatment of hepatitis C.. Blood cancer journal. 6:-. 2016
- Commentary on "Primary Care Providers' Comfort Levels in Caring for Patients With Sickle Cell Disease".. Southern medical journal. 108:537-8. 2015
- A Mixed-Methods Study of Pain-related Quality of Life in Sickle Cell Vaso-Occlusive Crises.. Hemoglobin. 39:305-9. 2015
- A novel role for microphthalmia-associated transcription factor-regulated pigment epithelium-derived factor during melanoma progression.. The American journal of pathology. 185:252-65. 2014
- A road less traveled.. Kidney international. 86:-. 2014
- Quality Assessment of Acute Inpatient Pain Management in an Academic Health Center.. The American journal of hospice & palliative care. 33:16-9. 2014
- Paraneoplastic thrombocytosis: the secrets of tumor self-promotion.. Blood. 124:184-7. 2014
- The Barriers to High-Quality Inpatient Pain Management: A Qualitative Study.. The American journal of hospice & palliative care. 32:594-9. 2014
- The sentinel hospitalization and the role of palliative care.. Journal of hospital medicine. 9:320-3. 2014
- The role of palliative care in medical education.. Annals of internal medicine. 159:848-9. 2013
- Silence.. Academic medicine : journal of the Association of American Medical Colleges. 88:-. 2013
- Paraneoplastic autoimmunity associated with testicular myeloid sarcoma and chronic myelomonocytic leukemia.. Case reports in hematology. -. 2013
- Anemia in general medical inpatients prolongs length of stay and increases 30-day unplanned readmission rate.. Southern medical journal. 106:316-20. 2013
- Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation.. Case reports in hematology. -. 2013
- Back to basics.. The clinical teacher. 10:56-7. 2013
- Away from home.. Journal of palliative medicine. 15:1392-3. 2012
- Commentary on "relation between prefracture characteristics and perioperative complications in the elderly adult patient with hip fracture".. Southern medical journal. 105:311-2. 2012
- A mysterious stroke in a colon cancer patient.. QJM : monthly journal of the Association of Physicians. 107:919-22. 2012
- Dyspnea in palliative care: expanding the role of corticosteroids.. Journal of palliative medicine. 15:834-7. 2012
- My very first narcotics prescription.. Journal of palliative medicine. 14:1178-9. 2011
- Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF.. Proceedings of the National Academy of Sciences of the United States of America. 108:E924-33. 2011
- An unusual cause of chest pain: Mycobacterium avium complex and the immune reconstitution inflammatory syndrome.. Journal of hospital medicine. 6:309-11. 2010
- Lenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma.. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 16:90-1. 2010
- Transcriptional regulation in acute promyelocytic leukemia.. Oncogene. 20:7204-15. 2001
- Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers.. Molecular cell. 5:821-30. 2000
- Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2.. Molecular endocrinology (Baltimore, Md.). 13:2151-62. 1999
- Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase.. Cell. 98:675-86. 1999
- Molecular genetics of acute promyelocytic leukemia.. Trends in genetics : TIG. 15:179-84. 1999
- The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression.. Nucleic acids research. 26:4645-51. 1998
- Role of the histone deacetylase complex in acute promyelocytic leukaemia.. Nature. 391:811-4. 1998
- The transcriptional basis of steroid physiology.. Cold Spring Harbor symposia on quantitative biology. 577-85. 1998
- Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.. Proceedings of the National Academy of Sciences of the United States of America. 94:10762-7. 1997
- Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.. Cell. 90:569-80. 1997
- Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase.. Cell. 89:373-80. 1997
- Role of calf RTH-1 nuclease in removal of 5'-ribonucleotides during Okazaki fragment processing.. Biochemistry. 35:9266-77. 1996